Masaharu Tanaka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Masaharu Tanaka has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Hiroyuki Yamamoto
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
3 shared publications - Yuki Maki
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
3 shared publications - Hiroyuki Kidokoro
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2 shared publications - Jun Natsume
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Developmental Disability Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan
2 shared publications - Masahiro Kawaguchi
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2 shared publications Takeshi Suzuki
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2 shared publications
Latest Publications
- 5 September 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 142, 181-186
Relationships between PRRT2 variants and clinical outcomes in infants with suspected self-limited infantile epilepsy
- 5 September 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 142, 181-186
Relationships between PRRT2 variants and clinical outcomes in infants with suspected self-limited infantile epilepsy
- 1 August 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 121 (Pt A) , 108075
Repetitive sleep starts: An important differential diagnosis of infantile spasms
- 1 August 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 121 (Pt A) , 108075
Repetitive sleep starts: An important differential diagnosis of infantile spasms
- 1 May 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 118, 107924
Risks of ACTH therapy for West syndrome following BCG vaccination
- 1 May 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 118, 107924
Risks of ACTH therapy for West syndrome following BCG vaccination
- Open Access
- 1 January 2008
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 21 (4) , 249-251
Acute Thrombus Formation in the Lungs of Phenylhydrazine-treated Rats
- 1 January 2008
- Published by Japanese Society of Toxicologic Pathology in Journal of Toxicologic Pathology
- Vol. 21 (4) , 249-251
Open AccessAcute Thrombus Formation in the Lungs of Phenylhydrazine-treated Rats
- Open Access
- 1 January 2000
- Published by Kurume Medical Journal in The Kurume Medical Journal
- Vol. 47 (1) , 31-36
Morphological Change in the MNNG-Treated Rat Gastric Mucosa.
To investigate the process of carcinogenesis in gastric cancer, we studied the histological features of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-treated rats. Samples of the gastric mucosa from both MNNG-treated and control rats were histologically examined every 2 months, for 10 months. In 40% of the MNNG-treated rats, atrophy in the gastric mucosa was observed after 2 months, and regenerative epithelium was observed after 4 months, followed by adenomatous proliferation and disappearance of the tight junction electron microscopically after 6 months. A small intestinal cancer had developed in 2 rats at 6 months. While gastric cancer had developed in 3 rats at 8 months, and in one of these 3 rats, peritoneal dissemination was observed macroscopically and histologically. These results suggested that adenomatous proliferation and disappearance of the tight junction observed electron microscopically were characteristic pathological features of precancerous lesions in the stomach in MNNG-treated rat.
- 1 January 2000
- Published by Kurume Medical Journal in The Kurume Medical Journal
- Vol. 47 (1) , 31-36
Open AccessMorphological Change in the MNNG-Treated Rat Gastric Mucosa.
To investigate the process of carcinogenesis in gastric cancer, we studied the histological features of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-treated rats. Samples of the gastric mucosa from both MNNG-treated and control rats were histologically examined every 2 months, for 10 months. In 40% of the MNNG-treated rats, atrophy in the gastric mucosa was observed after 2 months, and regenerative epithelium was observed after 4 months, followed by adenomatous proliferation and disappearance of the tight junction electron microscopically after 6 months. A small intestinal cancer had developed in 2 rats at 6 months. While gastric cancer had developed in 3 rats at 8 months, and in one of these 3 rats, peritoneal dissemination was observed macroscopically and histologically. These results suggested that adenomatous proliferation and disappearance of the tight junction observed electron microscopically were characteristic pathological features of precancerous lesions in the stomach in MNNG-treated rat.